06.03.2014 • News

Technip Wins Onshore FEED Bid for Peterhead CCS Project

Technip has won a contract from Shell UK to provide front-end engineering design (FEED) for the onshore elements of the Peterhead Gas Carbon Capture and Storage (CCS) demonstration project in Aberdeenshire, Scotland.

The Scottish project designed to capture, compress and transport by pipeline 1 million t/y of carbon dioxide to an offshore gas reservoir for long-term storage beneath the North Sea was chosen in 2013 as one of two CCS demonstration projects to progress to the next stage of the UK government's Department of Energy and Climate Change CCS competition.

It could be the first commercial CCS to be realized anywhere in the world.

The French engineering contractor said the FEED scope includes a grassroots carbon capture and compression plant and modifications to an existing combined cycle gas turbine power plant.

Technip's operating center in Milton Keynes, UK, which executed a pre-FEED study for the Peterhead CCS project in 2012, will handle the FEED for this phase.

Shell is developing the Peterhead CCS project with strategic support from SSE Generation, which owns and operates the Peterhead Power Station.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read